ABCL
$11.37-7.11%
AbCellera Biologics Inc. total returns by year (including dividends)
As of market close, Oct 22, 2026
AbCellera Biologics Inc. total returns by year (2021–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $3.42 | $11.37 | 0.0% | +232.5% | |
| 2025 | $2.93 | $3.42 | 0.0% | +16.7% | |
| 2024 | $5.71 | $2.93 | 0.0% | -48.7% | |
| 2023 | $10.13 | $5.71 | 0.0% | -43.6% | |
| 2022 | $14.30 | $10.13 | 0.0% | -29.2% | |
| 2021 | $40.24 | $14.30 | 0.0% | -64.5% |
- Annualized
- -19.6%
- 2021–2026
- Average year
- -33.8%
- 5 full years
- Best year
- +16.7%
- 2025
- Worst year
- -64.5%
- 2021
- Positive years
- 1/5
- 20% up
Annualized (CAGR)
-19.6%
2021–2026
Average year
-33.8%
5 full years
Best year
+16.7%
2025
Worst year
-64.5%
2021
Positive years
1/5
20% up
Total return by period#
Annual
-200%-100%0%100%200%
2021-64%'21
2022-29%'22
2023-44%'23
2024-49%'24
2025+17%'25
2026+232%'26
Methodology#
Total returns, dividends reinvested, measured on ABCL. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is AbCellera Biologics Inc.'s average annual return?
- Since 2021, AbCellera Biologics Inc. (ABCL) has returned about -19.6% a year (the compound annual growth rate) and an average calendar-year return of -33.8%.
- What were AbCellera Biologics Inc.'s best and worst years?
- Over 2021–2026, the best year was 2025 (+16.7%) and the worst was 2021 (-64.5%).
- How often is AbCellera Biologics Inc. up in a year?
- 1 of the 5 full years since 2021 were positive — about 20% of the time.
More on AbCellera Biologics Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100